It appears that the Sorrento Therapeutics (SRNE) stock is no longer trading actively as of date of writing. It may be because the stock trading may have been discontinued by the issuing organization, or may have been suspended from active trading owing to a variety of reasons, or it may be an error in FKnol.com records (please let us know). The following data about this stock is available as of writing in FKnol.com records, and may be obsolete. Sorrento Therapeutics has the following business profile:
Market and Trading Information for Sorrento Therapeutics
The following details were available for trading and market data about the stock of Sorrento Therapeutics as of writing:
Trading Details of Sorrento Therapeutics (SRNE)
Current Share Price:
$0.31
Previous Year's Closing Price:
$0.89
Percentage Price Change (YTD):
-65.32%
Market Cap:
$168.36 million
52-week Price Range:
$0.16 - $3.09
Dividend Per Share:
$0
EPS (TTM):
-1.53
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
-0.45
Company Profile and Business Description for Sorrento Therapeutics
Sorrento Therapeutics, Inc., incorporated on December 4, 2009, is a biopharmaceutical company. The Company is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. Its primary therapeutic focus is oncology, including the treatment of chronic cancer pain. I...to see full details, pleaseLogin / Register to view.
ETFs Holding Sorrento Therapeutics Stock
As of March 2020, the following exchange-traded funds (ETF) hold the Sorrento Therapeutics stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Sorrento Therapeutics stock holding. There are a total of 17 ETFs in Fknol.com records which are holding Sorrento Therapeutics stock in their portfolio. See Full List.
The Virtus LifeSci Biotech Clinical Trials ETF tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. ...Full Details
The iShares Core S&P Total U.S. Stock Market ETF tracks a market cap-weighted index of all common equities listed on the NYSE and the NASDAQ. ...Full Details
The iShares Microcap ETF tracks a market-cap-weighted index of U.S. micro-cap stocks. The index selects the smallest 1000 stocks in the Russell 2000 Index. ...Full Details
The iShares Russell 2000 ETF tracks a market-cap-weighted index of US small-cap stocks. The index selects stocks ranked 1,001-3,000 by market cap. ...Full Details ...Candlestick Patterns.
The iShares Russell 2000 Growth ETF tracks a market-cap-weighted index of US small-cap growth stocks. The index selects from stocks ranked 1001-3000 by market cap based on two growth factors. ...Full Details
The iShares Russell 3000 ETF tracks a cap-weighted index that measures the investable US equities market, covering the entire market-cap spectrum, including micro-caps. ...Full Details
The Invesco FTSE RAFI US 1500 Small-Mid ETF tracks a fundamentally weighted index of 1,500 small- and midcap companies in the FTSE USA All Cap Index. ...Full Details
See Full List of ETFs holding Sorrento Therapeutics stock in their respective portfolios.
U.S. Stock Screener:
Peer / Competitor Companies of Biotech-Commercial Physical Biological Research Sector
Along with Sorrento Therapeutics, Inc., the following other peer (competitor) companies also exist within the same Biotech-Commercial Physical Biological Research - Healthcare sector whose company profile and dividend history is as follows:
▶ Anavex Life Sciences (AVXL): Anavex Life Sciences Corp., incorporated on January 23, 2004, is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and ....See Detailed Company Profile, Dividend History
▶ Bioanalytical (BASI): Bioanalytical systems, Inc., incorporated on July 17, 1975, is an international contract research company providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers ....See Detailed Company Profile, Dividend History
▶ Charles River Laboratories International (CRL): Charles River Laboratories International, Inc., incorporated on February 3, 1994, is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and ....See Detailed Company Profile, Dividend History
▶ Cleveland BioLabs (CBLI): Cleveland BioLabs, Inc. (CBLI), incorporated on June 5, 2003, is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. ....See Detailed Company Profile, Dividend History
▶ Exact Sciences (EXAS): Exact Sciences Corporation, incorporated on February 10, 1995, is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. The Company offers ....See Detailed Company Profile, Dividend History
▶ Exelixis (EXEL): Exelixis, Inc., incorporated on November 15, 1994, is a biopharmaceutical company. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people ....See Detailed Company Profile, Dividend History
▶ ICON (ICLR): ICON public limited company, incorporated on May 31, 1989, is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device ....See Detailed Company Profile, Dividend History
▶ Incyte (INCY): Incyte Corporation, incorporated on April 8, 1991, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics. The Companys portfolio includes compounds in various ....See Detailed Company Profile, Dividend History
▶ Intrexon (XON): Intrexon Corporation (Intrexon), incorporated on May 21, 2014, forms collaborations to create biologically-based products and processes using synthetic biology. The Companys domestic operations are in California, Florida, Maryland, and Virginia, ....See Detailed Company Profile, Dividend History
▶ Luna Innovations (LUNA): Luna Innovations Incorporated, incorporated on April 4, 2003, develops, manufactures and markets fiber optic sensing and test, and measurement products. The Company is focused on bringing technology solutions to measure ....See Detailed Company Profile, Dividend History
▶ Medpace (MEDP): Medpace Holdings, Inc., incorporated on February 18, 2014, is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, ....See Detailed Company Profile, Dividend History
▶ NanoViricides (NNVC): NanoViricides, Inc., incorporated on April 1, 2005, is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its ....See Detailed Company Profile, Dividend History
▶ Pieris Pharma (PIRS): Pieris Pharmaceuticals, Inc., incorporated on May 24, 2013, is a clinical-stage biopharmaceutical company. The Companys pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled ....See Detailed Company Profile, Dividend History
▶ PRA Health Sciences (PRAH): PRA Health Sciences, Inc., incorporated on June 21, 2013, is a contract research organization (CRO). The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company ....See Detailed Company Profile, Dividend History
▶ Tenax Therapeutics (TENX): Tenax Therapeutics, Inc., incorporated on April 17, 2008, is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Companys ....See Detailed Company Profile, Dividend History